ALZAMEND NEURO INC ALZN

US Healthcare Pharmaceutical Preparations
$1.16
+3.6%
52w: $0.86 – $2.62

Latest 13F among current holders filed 8 days ago (Aug 25, 2026)

Price — last 12 months

research preview data
0.861.742.62
Aug 18, 2025 Jul 2, 2026
Institutional holders
13
+0 QoQ
13F value
$723K
+61.7% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$412K
Q1 2024
$150K
Q2 2024
$6K
Q2 2025
$351K
Q3 2025
$447K
Q4 2025
$723K
Q1 2026

Number of holders

14
Q1 2024
15
Q2 2024
8
Q2 2025
12
Q3 2025
13
Q4 2025
13
Q1 2026

Who owns ALZN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Kingsbury Capital Investment Advisors LLC 566.7K$601K
GEODE CAPITAL MANAGEMENT, LLC Index provider45.7K$48K+66.1%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical21.0K$22K
MORGAN STANLEY Bank broker18.0K$19K0.0%Held
Clearstead Advisors, LLC Wealth advisor10.0K$11K0.0%Held
Tower Research Capital LLC (TRC) Market maker6.2K$7K0.0%+197.2%
CITIGROUP INC Bank broker5.2K$6K0.0%New
UBS Group AG Bank broker4.5K$5K0.0%-81.7%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical4.4K$5K
BlackRock, Inc. Index provider437$4630.0%Held
SBI Securities Co., Ltd. Diversified mechanical22$230.0%Held
Caitong International Asset Management Co., Ltd Diversified mechanical4$4New
HARBOR INVESTMENT ADVISORY, LLC Diversified mechanical1$10.0%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.